Cryo Cell International (CCEL) Enterprise Value (2010 - 2026)

Cryo Cell International has disclosed Enterprise Value across 17 years of filings, most recently posting -$2.9 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 16.65% year-over-year to -$2.9 million; the TTM figure through Feb 2026 stood at -$2.9 million (up 16.65% YoY), while the FY2025 annual figure was -$3.3 million, up 5.72% from the prior year.
• Enterprise Value advanced to -$2.9 million in Q1 2026, from -$3.3 million in the prior quarter.
• Over the last five years, Enterprise Value for CCEL reached as high as -$979593.0 in Q1 2024 and fell as low as -$4.4 million in Q2 2025.
• The 5-year median for Enterprise Value is -$2.6 million (2022), against an average of -$2.5 million.
• Annual changes were most pronounced in 2022 — Enterprise Value soared 79.35% — and 2024, when it plunged 256.66%.
• A 5-year view of Enterprise Value shows it stood at -$1.7 million in 2022, then surged by 43.06% to -$980250.0 in 2023, then sank by 256.66% to -$3.5 million in 2024, then advanced by 5.72% to -$3.3 million in 2025, then gained by 12.01% to -$2.9 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$2.9 million, -$3.3 million, and -$3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.